In 2023, the mortality rate for stomach malignant neoplasms in Japan stood at 40.15 thousand deaths. Forecasted data indicates a gradual decline: from 39.46 thousand in 2024 to 36.86 thousand by 2028. Year-on-year variations show a steady decrease, reflecting a trend of improved outcomes over time. The five-year compound annual growth rate (CAGR) implies a reduction in mortality.
Future trends to watch for include advancements in early detection, prevention, and treatment. It's crucial to monitor healthcare system improvements and public health initiatives that can further diminish mortality rates while considering aging demographics and potential lifestyle changes.
